{"transactions":[{"id":725175,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-26T20:23:27.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on the earlier of (i) June 24, 2027 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2027 annual meeting of stockholders, subject to continued service with the Issuer."}],"balance_after":45000,"derivative":{"exercise_price":0.576,"expiration_date":"2036-06-23","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001628280-26-045789","document":"wk-form4_1782505405.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1792746/000162828026045789/wk-form4_1782505405.xml","form_type":"4"}},{"id":729976,"issuer":{"id":4569,"kind":"organization","name":"Kardigan, Inc."},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2026-06-22T23:30:23.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":79640,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on June 17, 2028, subject to the Reporting Person's continuous service as of the applicable vesting date."}],"balance_after":79640,"source":{"system":"sec-edgar","filing":"0001193125-26-277955","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1792746/000119312526277955/ownership.xml","form_type":"4"}},{"id":1112802,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-12T21:30:09.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":138900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on the earlier of (i) June 12, 2026 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2026 annual meeting of stockholders, subject to continued service with the Issuer."}],"balance_after":138900,"derivative":{"exercise_price":0.653,"expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":138900},"source":{"system":"sec-edgar","filing":"0001842952-25-000078","document":"wk-form4_1749763803.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1792746/000184295225000078/wk-form4_1749763803.xml","form_type":"4"}},{"id":1303120,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-15T01:43:51.000Z","date":"2025-01-13","kind":"grant","planned":false,"acquired":true,"shares":20685,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on the earlier of (i) June 13, 2025 or (ii) the Issuer's 2025 annual meeting of stockholders, subject to continued service with the Issuer."}],"balance_after":20685,"derivative":{"exercise_price":1.03,"expiration_date":"2035-01-12","underlying":"Common Stock","underlying_shares":20685},"source":{"system":"sec-edgar","filing":"0001842952-25-000010","document":"wk-form4_1736905424.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1792746/000184295225000010/wk-form4_1736905424.xml","form_type":"4"}},{"id":1763532,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Performance Restricted Stock Units","published_at":"2023-10-06T18:03:58.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5749,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU (as defined in footnote 4 to this Form 4) and PSU (as defined in footnote 8 to this Form 4) represents a contingent right to receive one Ordinary Share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Reflects the disposition of Issuer's restricted stock unit awards with performance-based vesting or delivery requirements (each, a \"PSU\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding PSU (whether or not vested) was canceled and converted into the right to receive cash, without interest, in an amount equal to (i) the total number of Ordinary Shares issuable in settlement of such PSU (as determined in accordance with the Transaction Agreement) multiplied by (ii) the Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"The Ordinary Shares subject to the PSUs vest 2/3rd on January 5, 2025 and the remaining shares vest on January 5, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F12","text":"The Ordinary Shares subject to the PSUs vest 2/3rd on January 5, 2025 and the remaining shares vest on January 5, 2026."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5749},"source":{"system":"sec-edgar","filing":"0001209191-23-052364","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123052364/doc4.xml","form_type":"4"}},{"id":1763531,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Performance Restricted Stock Units","published_at":"2023-10-06T18:03:58.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5749,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU (as defined in footnote 4 to this Form 4) and PSU (as defined in footnote 8 to this Form 4) represents a contingent right to receive one Ordinary Share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Reflects the disposition of Issuer's restricted stock unit awards with performance-based vesting or delivery requirements (each, a \"PSU\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding PSU (whether or not vested) was canceled and converted into the right to receive cash, without interest, in an amount equal to (i) the total number of Ordinary Shares issuable in settlement of such PSU (as determined in accordance with the Transaction Agreement) multiplied by (ii) the Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"The Ordinary Shares subject to the PSUs vest 2/3rd on January 5, 2025 and the remaining shares vest on January 5, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F12","text":"The Ordinary Shares subject to the PSUs vest 2/3rd on January 5, 2025 and the remaining shares vest on January 5, 2026."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5749},"source":{"system":"sec-edgar","filing":"0001209191-23-052364","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123052364/doc4.xml","form_type":"4"}},{"id":1763530,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Performance Restricted Stock Units","published_at":"2023-10-06T18:03:58.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":11499,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU (as defined in footnote 4 to this Form 4) and PSU (as defined in footnote 8 to this Form 4) represents a contingent right to receive one Ordinary Share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Reflects the disposition of Issuer's restricted stock unit awards with performance-based vesting or delivery requirements (each, a \"PSU\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding PSU (whether or not vested) was canceled and converted into the right to receive cash, without interest, in an amount equal to (i) the total number of Ordinary Shares issuable in settlement of such PSU (as determined in accordance with the Transaction Agreement) multiplied by (ii) the Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"The Ordinary Shares subject to the PSUs vest on January 5, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F11","text":"The Ordinary Shares subject to the PSUs vest on January 5, 2026."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":11499},"source":{"system":"sec-edgar","filing":"0001209191-23-052364","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123052364/doc4.xml","form_type":"4"}},{"id":1763529,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Performance Restricted Stock Units","published_at":"2023-10-06T18:03:58.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":23806,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU (as defined in footnote 4 to this Form 4) and PSU (as defined in footnote 8 to this Form 4) represents a contingent right to receive one Ordinary Share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Reflects the disposition of Issuer's restricted stock unit awards with performance-based vesting or delivery requirements (each, a \"PSU\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding PSU (whether or not vested) was canceled and converted into the right to receive cash, without interest, in an amount equal to (i) the total number of Ordinary Shares issuable in settlement of such PSU (as determined in accordance with the Transaction Agreement) multiplied by (ii) the Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The Ordinary Shares subject to the PSUs vest on January 5, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"The Ordinary Shares subject to the PSUs vest on January 5, 2025."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":23806},"source":{"system":"sec-edgar","filing":"0001209191-23-052364","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123052364/doc4.xml","form_type":"4"}},{"id":1763528,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Performance Restricted Stock Units","published_at":"2023-10-06T18:03:58.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":14282,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU (as defined in footnote 4 to this Form 4) and PSU (as defined in footnote 8 to this Form 4) represents a contingent right to receive one Ordinary Share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Reflects the disposition of Issuer's restricted stock unit awards with performance-based vesting or delivery requirements (each, a \"PSU\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding PSU (whether or not vested) was canceled and converted into the right to receive cash, without interest, in an amount equal to (i) the total number of Ordinary Shares issuable in settlement of such PSU (as determined in accordance with the Transaction Agreement) multiplied by (ii) the Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The Ordinary Shares subject to the PSUs vest on January 5, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"The Ordinary Shares subject to the PSUs vest on January 5, 2025."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":14282},"source":{"system":"sec-edgar","filing":"0001209191-23-052364","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123052364/doc4.xml","form_type":"4"}},{"id":1763527,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Performance Restricted Stock Units","published_at":"2023-10-06T18:03:58.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4761,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU (as defined in footnote 4 to this Form 4) and PSU (as defined in footnote 8 to this Form 4) represents a contingent right to receive one Ordinary Share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Reflects the disposition of Issuer's restricted stock unit awards with performance-based vesting or delivery requirements (each, a \"PSU\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding PSU (whether or not vested) was canceled and converted into the right to receive cash, without interest, in an amount equal to (i) the total number of Ordinary Shares issuable in settlement of such PSU (as determined in accordance with the Transaction Agreement) multiplied by (ii) the Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The Ordinary Shares subject to the PSUs vest 2/3rd on January 5, 2024 and the remaining shares vest on January 5, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"The Ordinary Shares subject to the PSUs vest 2/3rd on January 5, 2024 and the remaining shares vest on January 5, 2025."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":4761},"source":{"system":"sec-edgar","filing":"0001209191-23-052364","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123052364/doc4.xml","form_type":"4"}},{"id":1763526,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Performance Restricted Stock Units","published_at":"2023-10-06T18:03:58.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":34928,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU (as defined in footnote 4 to this Form 4) and PSU (as defined in footnote 8 to this Form 4) represents a contingent right to receive one Ordinary Share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Reflects the disposition of Issuer's restricted stock unit awards with performance-based vesting or delivery requirements (each, a \"PSU\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding PSU (whether or not vested) was canceled and converted into the right to receive cash, without interest, in an amount equal to (i) the total number of Ordinary Shares issuable in settlement of such PSU (as determined in accordance with the Transaction Agreement) multiplied by (ii) the Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The Ordinary Shares subject to the PSUs (as defined in footnote 8 to this Form 4) vest on January 5, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The Ordinary Shares subject to the PSUs (as defined in footnote 8 to this Form 4) vest on January 5, 2024."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":34928},"source":{"system":"sec-edgar","filing":"0001209191-23-052364","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123052364/doc4.xml","form_type":"4"}},{"id":1763525,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Performance Restricted Stock Units","published_at":"2023-10-06T18:03:58.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5816,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU (as defined in footnote 4 to this Form 4) and PSU (as defined in footnote 8 to this Form 4) represents a contingent right to receive one Ordinary Share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Reflects the disposition of Issuer's restricted stock unit awards with performance-based vesting or delivery requirements (each, a \"PSU\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding PSU (whether or not vested) was canceled and converted into the right to receive cash, without interest, in an amount equal to (i) the total number of Ordinary Shares issuable in settlement of such PSU (as determined in accordance with the Transaction Agreement) multiplied by (ii) the Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The Ordinary Shares subject to the PSUs (as defined in footnote 8 to this Form 4) vest on January 5, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The Ordinary Shares subject to the PSUs (as defined in footnote 8 to this Form 4) vest on January 5, 2024."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5816},"source":{"system":"sec-edgar","filing":"0001209191-23-052364","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123052364/doc4.xml","form_type":"4"}},{"id":1763524,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Performance Restricted Stock Units","published_at":"2023-10-06T18:03:58.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":15281,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU (as defined in footnote 4 to this Form 4) and PSU (as defined in footnote 8 to this Form 4) represents a contingent right to receive one Ordinary Share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Reflects the disposition of Issuer's restricted stock unit awards with performance-based vesting or delivery requirements (each, a \"PSU\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding PSU (whether or not vested) was canceled and converted into the right to receive cash, without interest, in an amount equal to (i) the total number of Ordinary Shares issuable in settlement of such PSU (as determined in accordance with the Transaction Agreement) multiplied by (ii) the Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The Ordinary Shares subject to the PSUs (as defined in footnote 8 to this Form 4) vest on January 5, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The Ordinary Shares subject to the PSUs (as defined in footnote 8 to this Form 4) vest on January 5, 2024."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":15281},"source":{"system":"sec-edgar","filing":"0001209191-23-052364","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123052364/doc4.xml","form_type":"4"}},{"id":1763523,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Restricted Stock Units","published_at":"2023-10-06T18:03:58.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":22997,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU (as defined in footnote 4 to this Form 4) and PSU (as defined in footnote 8 to this Form 4) represents a contingent right to receive one Ordinary Share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the disposition of Issuer's restricted stock unit awards, excluding PSUs (as defined in footnote 8 to this Form 4), (each, a \"RSU\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding RSU (whether or not vested) was assumed and converted into a restricted stock unit (each, a \"Parent RSU\") denominated in shares of Parent's common stock. The number of shares of Parent's common stock subject to each such Parent RSU was equal to the product (rounded down to the nearest whole number) of (y) the number of shares of Ordinary Shares subject to the RSU immediately prior to the Effective Time multiplied by (z) the ratio equal to (1) the Consideration divided by (2) the volume weighted average of the per share closing price of Parent's common stock on the Nasdaq for five (5) trading days ending on the second business day prior to the completion of the Scheme."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The Ordinary Shares subject to the RSUs vest 1/3rd annually on each anniversary of January 5, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The Ordinary Shares subject to the RSUs vest 1/3rd annually on each anniversary of January 5, 2023."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":22997},"source":{"system":"sec-edgar","filing":"0001209191-23-052364","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123052364/doc4.xml","form_type":"4"}},{"id":1763522,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Restricted Stock Units","published_at":"2023-10-06T18:03:58.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":15870,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU (as defined in footnote 4 to this Form 4) and PSU (as defined in footnote 8 to this Form 4) represents a contingent right to receive one Ordinary Share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the disposition of Issuer's restricted stock unit awards, excluding PSUs (as defined in footnote 8 to this Form 4), (each, a \"RSU\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding RSU (whether or not vested) was assumed and converted into a restricted stock unit (each, a \"Parent RSU\") denominated in shares of Parent's common stock. The number of shares of Parent's common stock subject to each such Parent RSU was equal to the product (rounded down to the nearest whole number) of (y) the number of shares of Ordinary Shares subject to the RSU immediately prior to the Effective Time multiplied by (z) the ratio equal to (1) the Consideration divided by (2) the volume weighted average of the per share closing price of Parent's common stock on the Nasdaq for five (5) trading days ending on the second business day prior to the completion of the Scheme."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Ordinary Shares subject to the RSUs vest 1/3rd annually on each anniversary of January 5, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Ordinary Shares subject to the RSUs vest 1/3rd annually on each anniversary of January 5, 2022."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":15870},"source":{"system":"sec-edgar","filing":"0001209191-23-052364","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123052364/doc4.xml","form_type":"4"}},{"id":1763521,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Restricted Stock Units","published_at":"2023-10-06T18:03:58.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":11643,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU (as defined in footnote 4 to this Form 4) and PSU (as defined in footnote 8 to this Form 4) represents a contingent right to receive one Ordinary Share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the disposition of Issuer's restricted stock unit awards, excluding PSUs (as defined in footnote 8 to this Form 4), (each, a \"RSU\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding RSU (whether or not vested) was assumed and converted into a restricted stock unit (each, a \"Parent RSU\") denominated in shares of Parent's common stock. The number of shares of Parent's common stock subject to each such Parent RSU was equal to the product (rounded down to the nearest whole number) of (y) the number of shares of Ordinary Shares subject to the RSU immediately prior to the Effective Time multiplied by (z) the ratio equal to (1) the Consideration divided by (2) the volume weighted average of the per share closing price of Parent's common stock on the Nasdaq for five (5) trading days ending on the second business day prior to the completion of the Scheme."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Ordinary Shares subject to the RSUs vest on January 5, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Ordinary Shares subject to the RSUs vest on January 5, 2024."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":11643},"source":{"system":"sec-edgar","filing":"0001209191-23-052364","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123052364/doc4.xml","form_type":"4"}},{"id":1763520,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Ordinary Shares","published_at":"2023-10-06T18:03:58.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":56338,"price":116.5,"value":6563377.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the disposition of ordinary shares of Horizon Therapeutics plc (\"Issuer\"), nominal value $0.0001 per share (\"Ordinary Shares\"), in connection with the consummation of the transactions contemplated by the Transaction Agreement (the \"Transaction Agreement\"), dated as of December 11, 2022, by and among Issuer, Amgen Inc. (\"Parent\"), and Pillartree Limited, a wholly owned subsidiary of Parent (\"Acquirer Sub\"), including the consummation of a scheme of arrangement under Chapter 1 of Part 9 of the Companies Act 2014 of Ireland (the \"Scheme\") pursuant to which Acquirer Sub acquired Issuer. Pursuant to the Transaction Agreement, on October 6, 2023, the effective time of the Scheme (the \"Effective Time\"), each outstanding Ordinary Share was converted into $116.50 in cash (the \"Consideration\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-052364","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123052364/doc4.xml","form_type":"4"}},{"id":2052427,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Ordinary Shares","published_at":"2023-01-18T16:19:20.000Z","date":"2023-01-17","kind":"sale","acquired":false,"shares":27129,"price":113.0275,"value":3066323.0475,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.00 to $113.0750 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":56338,"source":{"system":"sec-edgar","filing":"0001209191-23-003733","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123003733/doc4.xml","form_type":"4"}},{"id":2060350,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Restricted Stock Units (RSU)","published_at":"2023-01-06T17:38:49.000Z","date":"2023-01-04","kind":"grant","acquired":true,"shares":22997,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest 1/3rd annually on each anniversary of January 5, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest 1/3rd annually on each anniversary of January 5, 2023."}],"balance_after":22997,"derivative":{"underlying":"Ordinary Shares","underlying_shares":22997},"source":{"system":"sec-edgar","filing":"0001209191-23-002432","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123002432/doc4.xml","form_type":"4"}},{"id":2067386,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Restricted Stock Units (RSU)","published_at":"2023-01-04T16:14:48.000Z","date":"2022-12-30","kind":"exercise","acquired":false,"shares":7935,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each PSU/RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The remaining ordinary shares subject to the RSU vest ratably on January 5, 2024 and January 5, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The remaining ordinary shares subject to the RSU vest ratably on January 5, 2024 and January 5, 2025."}],"balance_after":15870,"derivative":{"underlying":"Ordinary Shares","underlying_shares":7935},"source":{"system":"sec-edgar","filing":"0001209191-23-000879","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123000879/doc4.xml","form_type":"4"}},{"id":2067385,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Restricted Stock Units (RSU)","published_at":"2023-01-04T16:14:48.000Z","date":"2022-12-30","kind":"exercise","acquired":false,"shares":11643,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each PSU/RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The remaining ordinary shares subject to the PSU/RSU vest on January 5, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The remaining ordinary shares subject to the PSU/RSU vest on January 5, 2024."}],"balance_after":11643,"derivative":{"underlying":"Ordinary Shares","underlying_shares":11643},"source":{"system":"sec-edgar","filing":"0001209191-23-000879","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123000879/doc4.xml","form_type":"4"}},{"id":2067384,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Restricted Stock Units (RSU)","published_at":"2023-01-04T16:14:48.000Z","date":"2022-12-30","kind":"exercise","acquired":false,"shares":14514,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each PSU/RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The final tranche of ordinary shares subject to the PSU/RSU vested on December 30, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The final tranche of ordinary shares subject to the PSU/RSU vested on December 30, 2022."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":14514},"source":{"system":"sec-edgar","filing":"0001209191-23-000879","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123000879/doc4.xml","form_type":"4"}},{"id":2067383,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Performance Restricted Stock Units (PSU)","published_at":"2023-01-04T16:14:48.000Z","date":"2022-12-30","kind":"exercise","acquired":false,"shares":11648,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each PSU/RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The remaining ordinary shares subject to the PSU/RSU vest on January 5, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The remaining ordinary shares subject to the PSU/RSU vest on January 5, 2024."}],"balance_after":5816,"derivative":{"underlying":"Ordinary Shares","underlying_shares":11648},"source":{"system":"sec-edgar","filing":"0001209191-23-000879","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123000879/doc4.xml","form_type":"4"}},{"id":2067382,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Performance Restricted Stock Units (PSU)","published_at":"2023-01-04T16:14:48.000Z","date":"2022-12-30","kind":"exercise","acquired":false,"shares":26124,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each PSU/RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The final tranche of ordinary shares subject to the PSU/RSU vested on December 30, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The final tranche of ordinary shares subject to the PSU/RSU vested on December 30, 2022."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":26124},"source":{"system":"sec-edgar","filing":"0001209191-23-000879","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123000879/doc4.xml","form_type":"4"}},{"id":2067381,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Performance Restricted Stock Units (PSU)","published_at":"2023-01-04T16:14:48.000Z","date":"2022-12-30","kind":"exercise","acquired":false,"shares":5800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each PSU/RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The final tranche of ordinary shares subject to the PSU/RSU vested on December 30, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The final tranche of ordinary shares subject to the PSU/RSU vested on December 30, 2022."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5800},"source":{"system":"sec-edgar","filing":"0001209191-23-000879","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123000879/doc4.xml","form_type":"4"}},{"id":2067380,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Performance Restricted Stock Units (PSU)","published_at":"2023-01-04T16:14:48.000Z","date":"2022-12-30","kind":"exercise","acquired":false,"shares":2360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each PSU/RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The final tranche of ordinary shares subject to the PSU/RSU vested on December 30, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The final tranche of ordinary shares subject to the PSU/RSU vested on December 30, 2022."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2360},"source":{"system":"sec-edgar","filing":"0001209191-23-000879","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123000879/doc4.xml","form_type":"4"}},{"id":2067379,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Performance Restricted Stock Units (PSU)","published_at":"2023-01-04T16:14:48.000Z","date":"2022-12-30","kind":"exercise","acquired":false,"shares":8709,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each PSU/RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The final tranche of ordinary shares subject to the PSU/RSU vested on December 30, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The final tranche of ordinary shares subject to the PSU/RSU vested on December 30, 2022."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":8709},"source":{"system":"sec-edgar","filing":"0001209191-23-000879","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123000879/doc4.xml","form_type":"4"}},{"id":2067378,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Ordinary Shares","published_at":"2023-01-04T16:14:48.000Z","date":"2022-12-30","kind":"tax_withholding","acquired":false,"shares":39313,"price":113.8,"value":4473819.4,"ownership":{"direct":true},"balance_after":83467,"source":{"system":"sec-edgar","filing":"0001209191-23-000879","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123000879/doc4.xml","form_type":"4"}},{"id":2067377,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Ordinary Shares","published_at":"2023-01-04T16:14:48.000Z","date":"2022-12-30","kind":"exercise","acquired":true,"shares":88733,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each PSU/RSU represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":122780,"source":{"system":"sec-edgar","filing":"0001209191-23-000879","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123000879/doc4.xml","form_type":"4"}},{"id":2074933,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Performance Restricted Stock Units (PSUs)","published_at":"2022-12-29T16:28:38.000Z","date":"2022-12-27","kind":"grant","acquired":true,"shares":17464,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each PSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F3","text":"On January 4, 2021, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On December 27, 2022, such performance criteria were met.  Two-thirds of the ordinary shares subject to the PSUs vest on December 30, 2022 and the remaining one-third of the ordinary shares vest on January 5, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 4, 2021, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On December 27, 2022, such performance criteria were met.  Two-thirds of the ordinary shares subject to the PSUs vest on December 30, 2022 and the remaining one-third of the ordinary shares vest on January 5, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On January 4, 2021, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On December 27, 2022, such performance criteria were met.  Two-thirds of the ordinary shares subject to the PSUs vest on December 30, 2022 and the remaining one-third of the ordinary shares vest on January 5, 2024."}],"balance_after":17464,"derivative":{"underlying":"Ordinary Shares","underlying_shares":17464},"source":{"system":"sec-edgar","filing":"0001209191-22-062916","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122062916/doc4.xml","form_type":"4"}},{"id":2074932,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Performance Restricted Stock Units (PSUs)","published_at":"2022-12-29T16:28:38.000Z","date":"2022-12-27","kind":"grant","acquired":true,"shares":26124,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each PSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On January 3, 2020, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On December 27, 2022, such performance criteria were met. The ordinary shares subject to the PSUs vest on December 30, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 3, 2020, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On December 27, 2022, such performance criteria were met. The ordinary shares subject to the PSUs vest on December 30, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On January 3, 2020, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On December 27, 2022, such performance criteria were met. The ordinary shares subject to the PSUs vest on December 30, 2022."}],"balance_after":26124,"derivative":{"underlying":"Ordinary Shares","underlying_shares":26124},"source":{"system":"sec-edgar","filing":"0001209191-22-062916","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122062916/doc4.xml","form_type":"4"}},{"id":2086449,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-14T17:10:57.000Z","date":"2022-12-13","kind":"exercise","acquired":false,"shares":23251,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":29.52,"expiration_date":"2029-10-31","underlying":"Ordinary Shares","underlying_shares":23251},"source":{"system":"sec-edgar","filing":"0001209191-22-061269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122061269/doc4.xml","form_type":"4"}},{"id":2086448,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Ordinary Shares","published_at":"2022-12-14T17:10:57.000Z","date":"2022-12-13","kind":"sale","acquired":false,"shares":6918,"price":112.5997,"value":778964.7246,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.5950 to $112.60 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":34047,"source":{"system":"sec-edgar","filing":"0001209191-22-061269","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122061269/doc4.xml","form_type":"4"}},{"id":2086447,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Ordinary Shares","published_at":"2022-12-14T17:10:57.000Z","date":"2022-12-13","kind":"sale","acquired":false,"shares":23251,"price":112.6062,"value":2618206.7562,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.555 to $112.6701 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":40965,"source":{"system":"sec-edgar","filing":"0001209191-22-061269","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122061269/doc4.xml","form_type":"4"}},{"id":2086446,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Ordinary Shares","published_at":"2022-12-14T17:10:57.000Z","date":"2022-12-13","kind":"exercise","acquired":true,"shares":23251,"price":29.52,"value":686369.52,"ownership":{"direct":true},"balance_after":64216,"source":{"system":"sec-edgar","filing":"0001209191-22-061269","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122061269/doc4.xml","form_type":"4"}},{"id":2127094,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Restricted Stock Units","published_at":"2022-11-02T16:12:33.000Z","date":"2022-11-01","kind":"exercise","acquired":true,"shares":12421,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the restricted stock units vest in three equal annual installments, beginning November 1, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The shares subject to the restricted stock units vest in three equal annual installments, beginning November 1, 2020."}],"balance_after":0,"derivative":{"underlying":"Ordinary shares","underlying_shares":12421},"source":{"system":"sec-edgar","filing":"0001209191-22-055272","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122055272/doc4.xml","form_type":"4"}},{"id":2127093,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2022-11-02T16:12:33.000Z","date":"2022-11-01","kind":"tax_withholding","acquired":false,"shares":5503,"price":63.18,"value":347679.54,"ownership":{"direct":true},"balance_after":40965,"source":{"system":"sec-edgar","filing":"0001209191-22-055272","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122055272/doc4.xml","form_type":"4"}},{"id":2127092,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2022-11-02T16:12:33.000Z","date":"2022-11-01","kind":"exercise","acquired":true,"shares":12421,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":46468,"source":{"system":"sec-edgar","filing":"0001209191-22-055272","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122055272/doc4.xml","form_type":"4"}},{"id":2200193,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2022-07-29T17:21:12.000Z","date":"2022-07-29","kind":"sale","acquired":false,"shares":643,"price":83.45,"value":53658.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.10 to $83.57 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":34047,"source":{"system":"sec-edgar","filing":"0001209191-22-043548","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122043548/doc4.xml","form_type":"4"}},{"id":2200192,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2022-07-29T17:21:12.000Z","date":"2022-07-29","kind":"sale","acquired":false,"shares":4207,"price":82.44,"value":346825.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.05 to $82.99 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":34690,"source":{"system":"sec-edgar","filing":"0001209191-22-043548","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122043548/doc4.xml","form_type":"4"}},{"id":2234151,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2022-06-13T16:19:42.000Z","date":"2022-06-10","kind":"sale","acquired":false,"shares":762,"price":85.36,"value":65044.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2022."}],"balance_after":38897,"source":{"system":"sec-edgar","filing":"0001209191-22-036299","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122036299/doc4.xml","form_type":"4"}},{"id":2385306,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2022-02-18T16:42:45.000Z","date":"2022-02-18","kind":"sale","acquired":false,"shares":1313,"price":94.82,"value":124498.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2021."}],"balance_after":39659,"source":{"system":"sec-edgar","filing":"0001209191-22-011331","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122011331/doc4.xml","form_type":"4"}},{"id":2441463,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Restricted Stock Units (RSU)","published_at":"2022-01-06T21:02:00.000Z","date":"2022-01-05","kind":"exercise","acquired":false,"shares":11616,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Two-thirds of the ordinary shares subject to the RSUs vest on January 5, 2022 and the remaining one-third of the ordinary shares vest on January 5, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"Two-thirds of the ordinary shares subject to the RSUs vest on January 5, 2022 and the remaining one-third of the ordinary shares vest on January 5, 2023."}],"balance_after":5800,"derivative":{"underlying":"Ordinary Shares","underlying_shares":11616},"source":{"system":"sec-edgar","filing":"0001209191-22-002297","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122002297/doc4.xml","form_type":"4"}},{"id":2441462,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Restricted Stock Units (RSU)","published_at":"2022-01-06T21:02:00.000Z","date":"2022-01-05","kind":"exercise","acquired":false,"shares":11067,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"50% of the shares subject to the RSU's vested on 1/5/2022, and the remaining shares vest on 1/5/2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"50% of the shares subject to the RSU's vested on 1/5/2022, and the remaining shares vest on 1/5/2023."}],"balance_after":11069,"derivative":{"underlying":"Ordinary Shares","underlying_shares":11067},"source":{"system":"sec-edgar","filing":"0001209191-22-002297","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122002297/doc4.xml","form_type":"4"}},{"id":2441461,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Restricted Stock Units (RSU)","published_at":"2022-01-06T21:02:00.000Z","date":"2022-01-05","kind":"exercise","acquired":false,"shares":11642,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2021."}],"balance_after":23286,"derivative":{"underlying":"Ordinary Shares","underlying_shares":11642},"source":{"system":"sec-edgar","filing":"0001209191-22-002297","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122002297/doc4.xml","form_type":"4"}},{"id":2441460,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Restricted Stock Units (RSU)","published_at":"2022-01-06T21:02:00.000Z","date":"2022-01-05","kind":"exercise","acquired":false,"shares":14514,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2021."}],"balance_after":14514,"derivative":{"underlying":"Ordinary Shares","underlying_shares":14514},"source":{"system":"sec-edgar","filing":"0001209191-22-002297","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122002297/doc4.xml","form_type":"4"}},{"id":2441459,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Restricted Stock Units (RSU)","published_at":"2022-01-06T21:02:00.000Z","date":"2022-01-04","kind":"grant","acquired":true,"shares":23805,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2022."}],"balance_after":23805,"derivative":{"underlying":"Ordinary Shares","underlying_shares":23805},"source":{"system":"sec-edgar","filing":"0001209191-22-002297","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122002297/doc4.xml","form_type":"4"}},{"id":2441458,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2022-01-06T21:02:00.000Z","date":"2022-01-06","kind":"sale","acquired":false,"shares":349,"price":100.23,"value":34980.27,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.05 to $100.62 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":40972,"source":{"system":"sec-edgar","filing":"0001209191-22-002297","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122002297/doc4.xml","form_type":"4"}},{"id":2441457,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2022-01-06T21:02:00.000Z","date":"2022-01-06","kind":"sale","acquired":false,"shares":6438,"price":99.85,"value":642834.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.99 to $99.95 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":41321,"source":{"system":"sec-edgar","filing":"0001209191-22-002297","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122002297/doc4.xml","form_type":"4"}},{"id":2441456,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2022-01-06T21:02:00.000Z","date":"2022-01-06","kind":"sale","acquired":false,"shares":700,"price":98.33,"value":68831.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.95 to $98.79 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":47759,"source":{"system":"sec-edgar","filing":"0001209191-22-002297","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122002297/doc4.xml","form_type":"4"}},{"id":2441455,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2022-01-06T21:02:00.000Z","date":"2022-01-06","kind":"sale","acquired":false,"shares":500,"price":97.3,"value":48650.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.83 to $97.65 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":48459,"source":{"system":"sec-edgar","filing":"0001209191-22-002297","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122002297/doc4.xml","form_type":"4"}},{"id":2441454,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2022-01-06T21:02:00.000Z","date":"2022-01-05","kind":"tax_withholding","acquired":false,"shares":21710,"price":101.84,"value":2210946.4,"ownership":{"direct":true},"balance_after":48959,"source":{"system":"sec-edgar","filing":"0001209191-22-002297","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122002297/doc4.xml","form_type":"4"}},{"id":2441453,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2022-01-06T21:02:00.000Z","date":"2022-01-05","kind":"exercise","acquired":true,"shares":48839,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":70669,"source":{"system":"sec-edgar","filing":"0001209191-22-002297","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122002297/doc4.xml","form_type":"4"}},{"id":2480614,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2021-12-08T18:35:33.000Z","date":"2021-12-07","kind":"sale","acquired":false,"shares":1525,"price":100,"value":152500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2021."}],"balance_after":21830,"source":{"system":"sec-edgar","filing":"0001209191-21-068601","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121068601/doc4.xml","form_type":"4"}},{"id":2522845,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-05T17:00:26.000Z","date":"2021-11-04","kind":"exercise","acquired":false,"shares":23251,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The stock option is fully vested and exercisable."}],"balance_after":23251,"derivative":{"exercise_price":29.52,"expiration_date":"2029-10-31","underlying":"Ordinary Shares","underlying_shares":23251},"source":{"system":"sec-edgar","filing":"0001209191-21-063201","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121063201/doc4.xml","form_type":"4"}},{"id":2522844,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2021-11-05T17:00:26.000Z","date":"2021-11-04","kind":"sale","acquired":false,"shares":7264,"price":115.51,"value":839064.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2021."}],"balance_after":23355,"source":{"system":"sec-edgar","filing":"0001209191-21-063201","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121063201/doc4.xml","form_type":"4"}},{"id":2522843,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2021-11-05T17:00:26.000Z","date":"2021-11-04","kind":"sale","acquired":false,"shares":2728,"price":114.49,"value":312328.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.24 to $115.12 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":30619,"source":{"system":"sec-edgar","filing":"0001209191-21-063201","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121063201/doc4.xml","form_type":"4"}},{"id":2522842,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2021-11-05T17:00:26.000Z","date":"2021-11-04","kind":"sale","acquired":false,"shares":5650,"price":113.54,"value":641501.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.07 to $114.03 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":33347,"source":{"system":"sec-edgar","filing":"0001209191-21-063201","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121063201/doc4.xml","form_type":"4"}},{"id":2522841,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2021-11-05T17:00:26.000Z","date":"2021-11-04","kind":"sale","acquired":false,"shares":2706,"price":112.44,"value":304262.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.00 to $112.97 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":38997,"source":{"system":"sec-edgar","filing":"0001209191-21-063201","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121063201/doc4.xml","form_type":"4"}},{"id":2522840,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2021-11-05T17:00:26.000Z","date":"2021-11-04","kind":"sale","acquired":false,"shares":6336,"price":111.47,"value":706273.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.005 to $111.97 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":41703,"source":{"system":"sec-edgar","filing":"0001209191-21-063201","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121063201/doc4.xml","form_type":"4"}},{"id":2522839,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2021-11-05T17:00:26.000Z","date":"2021-11-04","kind":"sale","acquired":false,"shares":5484,"price":110.64,"value":606749.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.00 to $110.985 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":48039,"source":{"system":"sec-edgar","filing":"0001209191-21-063201","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121063201/doc4.xml","form_type":"4"}},{"id":2522838,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2021-11-05T17:00:26.000Z","date":"2021-11-04","kind":"exercise","acquired":true,"shares":23251,"price":29.52,"value":686369.52,"ownership":{"direct":true},"balance_after":53523,"source":{"system":"sec-edgar","filing":"0001209191-21-063201","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121063201/doc4.xml","form_type":"4"}},{"id":2526221,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Restricted Stock Units","published_at":"2021-11-03T16:31:47.000Z","date":"2021-11-01","kind":"exercise","acquired":true,"shares":12421,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the restricted stock units vest in three equal annual installments, beginning November 1, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The shares subject to the restricted stock units vest in three equal annual installments, beginning November 1, 2020."}],"balance_after":12421,"derivative":{"underlying":"Ordinary shares","underlying_shares":12421},"source":{"system":"sec-edgar","filing":"0001209191-21-062706","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121062706/doc4.xml","form_type":"4"}},{"id":2526220,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2021-11-03T16:31:47.000Z","date":"2021-11-01","kind":"tax_withholding","acquired":false,"shares":5503,"price":118.29,"value":650949.87,"ownership":{"direct":true},"balance_after":30272,"source":{"system":"sec-edgar","filing":"0001209191-21-062706","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121062706/doc4.xml","form_type":"4"}},{"id":2526219,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2021-11-03T16:31:47.000Z","date":"2021-11-01","kind":"exercise","acquired":true,"shares":12421,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":35775,"source":{"system":"sec-edgar","filing":"0001209191-21-062706","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121062706/doc4.xml","form_type":"4"}},{"id":2571938,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-13T20:00:16.000Z","date":"2021-09-09","kind":"exercise","acquired":false,"shares":23250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option is fully vested and exercisable."}],"balance_after":46502,"derivative":{"exercise_price":29.52,"expiration_date":"2029-10-31","underlying":"Ordinary Shares","underlying_shares":23250},"source":{"system":"sec-edgar","filing":"0001209191-21-055769","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121055769/doc4.xml","form_type":"4"}},{"id":2571937,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2021-09-13T20:00:16.000Z","date":"2021-09-09","kind":"sale","acquired":false,"shares":496,"price":108.26,"value":53696.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2021."}],"balance_after":23354,"source":{"system":"sec-edgar","filing":"0001209191-21-055769","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121055769/doc4.xml","form_type":"4"}},{"id":2571936,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2021-09-13T20:00:16.000Z","date":"2021-09-09","kind":"sale","acquired":false,"shares":22754,"price":107.83,"value":2453563.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.235 to $108.20 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":23850,"source":{"system":"sec-edgar","filing":"0001209191-21-055769","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121055769/doc4.xml","form_type":"4"}},{"id":2571935,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2021-09-13T20:00:16.000Z","date":"2021-09-09","kind":"exercise","acquired":true,"shares":23250,"price":29.52,"value":686340.0,"ownership":{"direct":true},"balance_after":46604,"source":{"system":"sec-edgar","filing":"0001209191-21-055769","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121055769/doc4.xml","form_type":"4"}},{"id":2621188,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Performance Restricted Stock Units (PSUs)","published_at":"2021-07-30T16:26:56.000Z","date":"2021-07-28","kind":"grant","acquired":true,"shares":17418,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each PSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 3, 2020, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On July 28, 2021, such performance criteria were met, and the PSUs vested as to the number of shares reported in Table I above.  The remaining ordinary shares subject to the PSUs vest in equal annual installments on January 5, 2022 and January 5, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On January 3, 2020, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On July 28, 2021, such performance criteria were met, and the PSUs vested as to the number of shares reported in Table I above.  The remaining ordinary shares subject to the PSUs vest in equal annual installments on January 5, 2022 and January 5, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On January 3, 2020, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On July 28, 2021, such performance criteria were met, and the PSUs vested as to the number of shares reported in Table I above.  The remaining ordinary shares subject to the PSUs vest in equal annual installments on January 5, 2022 and January 5, 2023."}],"balance_after":17418,"derivative":{"underlying":"Ordinary Shares","underlying_shares":17418},"source":{"system":"sec-edgar","filing":"0001209191-21-048790","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121048790/doc4.xml","form_type":"4"}},{"id":2621187,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2021-07-30T16:26:56.000Z","date":"2021-07-28","kind":"tax_withholding","acquired":false,"shares":3858,"price":102.5,"value":395445.0,"ownership":{"direct":true},"balance_after":23354,"source":{"system":"sec-edgar","filing":"0001209191-21-048790","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121048790/doc4.xml","form_type":"4"}},{"id":2621186,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2021-07-30T16:26:56.000Z","date":"2021-07-28","kind":"grant","acquired":true,"shares":8708,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 3, 2020, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On July 28, 2021, such performance criteria were met, and the PSUs vested as to the number of shares reported in Table I above.  The remaining ordinary shares subject to the PSUs vest in equal annual installments on January 5, 2022 and January 5, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 762 ordinary shares of the Issuer acquired by the reporting person on June 1, 2021 pursuant to an employee stock purchase program."}],"balance_after":27212,"source":{"system":"sec-edgar","filing":"0001209191-21-048790","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121048790/doc4.xml","form_type":"4"}},{"id":2846173,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Performance Restricted Stock Units (PSUs)","published_at":"2021-02-19T17:00:53.000Z","date":"2021-02-17","kind":"grant","acquired":true,"shares":17416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each PSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F3","text":"On January 3, 2020, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On February 17, 2021, such performance criteria were met. Two-thirds of the ordinary shares subject to the PSUs vest on January 5, 2022 and the remaining one-third of the ordinary shares vest on January 5, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 3, 2020, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On February 17, 2021, such performance criteria were met. Two-thirds of the ordinary shares subject to the PSUs vest on January 5, 2022 and the remaining one-third of the ordinary shares vest on January 5, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On January 3, 2020, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On February 17, 2021, such performance criteria were met. Two-thirds of the ordinary shares subject to the PSUs vest on January 5, 2022 and the remaining one-third of the ordinary shares vest on January 5, 2023."}],"balance_after":17416,"derivative":{"underlying":"Ordinary Shares","underlying_shares":17416},"source":{"system":"sec-edgar","filing":"0001209191-21-012414","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121012414/doc4.xml","form_type":"4"}},{"id":2846172,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Performance Restricted Stock Units (PSUs)","published_at":"2021-02-19T17:00:53.000Z","date":"2021-02-17","kind":"grant","acquired":true,"shares":4718,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each PSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 3, 2020, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On February 17, 2021, such performance criteria were met, and the PSUs vested as to the number of shares reported in Table I above.  The remaining ordinary shares subject to the PSUs vest in equal annual installments on January 5, 2022 and January 5, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On January 3, 2020, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On February 17, 2021, such performance criteria were met, and the PSUs vested as to the number of shares reported in Table I above.  The remaining ordinary shares subject to the PSUs vest in equal annual installments on January 5, 2022 and January 5, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On January 3, 2020, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On February 17, 2021, such performance criteria were met, and the PSUs vested as to the number of shares reported in Table I above.  The remaining ordinary shares subject to the PSUs vest in equal annual installments on January 5, 2022 and January 5, 2023."}],"balance_after":4718,"derivative":{"underlying":"Ordinary Shares","underlying_shares":4718},"source":{"system":"sec-edgar","filing":"0001209191-21-012414","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121012414/doc4.xml","form_type":"4"}},{"id":2846171,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2021-02-19T17:00:53.000Z","date":"2021-02-17","kind":"tax_withholding","acquired":false,"shares":1045,"price":87.17,"value":91092.65,"ownership":{"direct":true},"balance_after":17742,"source":{"system":"sec-edgar","filing":"0001209191-21-012414","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121012414/doc4.xml","form_type":"4"}},{"id":2846170,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2021-02-19T17:00:53.000Z","date":"2021-02-17","kind":"grant","acquired":true,"shares":2358,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 3, 2020, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On February 17, 2021, such performance criteria were met, and the PSUs vested as to the number of shares reported in Table I above.  The remaining ordinary shares subject to the PSUs vest in equal annual installments on January 5, 2022 and January 5, 2023."}],"balance_after":18787,"source":{"system":"sec-edgar","filing":"0001209191-21-012414","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121012414/doc4.xml","form_type":"4"}},{"id":2915562,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Restricted Stock Units (RSU)","published_at":"2021-01-06T21:14:25.000Z","date":"2021-01-05","kind":"disposition_to_issuer","acquired":false,"shares":14513,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2020."}],"balance_after":29028,"derivative":{"underlying":"Ordinary Shares","underlying_shares":14513},"source":{"system":"sec-edgar","filing":"0001209191-21-002421","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121002421/doc4.xml","form_type":"4"}},{"id":2915561,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Restricted Stock Units (RSU)","published_at":"2021-01-06T21:14:25.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":34928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2020."}],"balance_after":34928,"derivative":{"underlying":"Ordinary Shares","underlying_shares":34928},"source":{"system":"sec-edgar","filing":"0001209191-21-002421","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121002421/doc4.xml","form_type":"4"}},{"id":2915560,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2021-01-06T21:14:25.000Z","date":"2021-01-05","kind":"tax_withholding","acquired":false,"shares":6526,"price":73.28,"value":478225.28,"ownership":{"direct":true},"balance_after":16429,"source":{"system":"sec-edgar","filing":"0001209191-21-002421","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121002421/doc4.xml","form_type":"4"}},{"id":2915559,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2021-01-06T21:14:25.000Z","date":"2021-01-05","kind":"exercise","acquired":true,"shares":14513,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":22955,"source":{"system":"sec-edgar","filing":"0001209191-21-002421","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121002421/doc4.xml","form_type":"4"}},{"id":2994796,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Restricted Stock Units","published_at":"2020-11-03T16:25:31.000Z","date":"2020-11-01","kind":"exercise","acquired":true,"shares":12420,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the restricted stock units vest in three equal annual installments, beginning November 1, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares subject to the restricted stock units vest in three equal annual installments, beginning November 1, 2020."}],"balance_after":24842,"derivative":{"underlying":"Ordinary shares","underlying_shares":12420},"source":{"system":"sec-edgar","filing":"0001209191-20-056623","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919120056623/doc4.xml","form_type":"4"}},{"id":2994795,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2020-11-03T16:25:31.000Z","date":"2020-11-01","kind":"tax_withholding","acquired":false,"shares":5503,"price":74.93,"value":412339.79,"ownership":{"direct":true},"balance_after":8442,"source":{"system":"sec-edgar","filing":"0001209191-20-056623","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919120056623/doc4.xml","form_type":"4"}},{"id":2994794,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2020-11-03T16:25:31.000Z","date":"2020-11-01","kind":"exercise","acquired":true,"shares":12420,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,525 ordinary shares of the Issuer acquired by the reporting person on June 1, 2020 pursuant to an employee stock purchase program."}],"balance_after":13945,"source":{"system":"sec-edgar","filing":"0001209191-20-056623","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919120056623/doc4.xml","form_type":"4"}},{"id":3316328,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Restricted Stock Units (RSU)","published_at":"2020-01-07T18:20:57.000Z","date":"2020-01-03","kind":"grant","acquired":true,"shares":43541,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2020."}],"balance_after":43541,"derivative":{"underlying":"Ordinary Shares","underlying_shares":43541},"source":{"system":"sec-edgar","filing":"0001209191-20-002342","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919120002342/doc4.xml","form_type":"4"}},{"id":3380249,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Restricted Stock Units","published_at":"2019-11-05T17:04:05.000Z","date":"2019-11-01","kind":"grant","acquired":true,"shares":37262,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the restricted stock units shall vest in three equal annual installments, beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":37262,"derivative":{"underlying":"Ordinary shares","underlying_shares":37262},"source":{"system":"sec-edgar","filing":"0001209191-19-055269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919119055269/doc4.xml","form_type":"4"}},{"id":3380248,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-05T17:04:05.000Z","date":"2019-11-01","kind":"grant","acquired":true,"shares":69752,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the stock option shall vest in three equal annual installments, beginning on the first anniversary of the grant date."}],"balance_after":69752,"derivative":{"exercise_price":29.52,"expiration_date":"2029-10-31","underlying":"Ordinary shares","underlying_shares":69752},"source":{"system":"sec-edgar","filing":"0001209191-19-055269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919119055269/doc4.xml","form_type":"4"}}]}